MediPurpose President Randy Prather said Medikus was judiciously selected from other Austrian medical device distributors that also had expressed interest in babyLance(r)
"Medikus emerged as a confident choice because they demonstrated an aggressive capability to promote this exciting new heel stick device in the Austrian medical product marketplace,"
Although a relatively small market, Austria has a high level of per capita spending on medical devices. According to Espicom Business Intelligence, the Austrian market for medical equipment and supplies is valued at US $2.1 billion, equal to US $251 per capita, and is forecast to reach US $2.3 billion by 2015.
A complement to the company's vastly popular line of SurgiLance(r)
* The babyLance(r)
* The babyLance(r)
First introduced to the North American medical product marketplace in 2010, babyLance(r)
"As with our SurgiLance(r)
In particular, the babyLance(r)
* Ease of activation: Reduces trigger activation force, thereby significantly reducing the risk of bruising.
* Unique positioning design: Facilitates a stable and accurate placement against the targeted section of the infant's heel while ensuring the procedure can be performed consistently and quickly.
* Compliance with regulatory and quality standards: Manufactured to the same regulatory and quality standards as the SurgiLance(r)
* Cost effectiveness:
More information about babyLance(r)--
# # #
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular SurgiLance(r)
MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.